Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review. | Ann Clin Transl Neurol | 2022 | 36204816 | PubTator, text mining | PubMed |
| Editorial: Molecules of the extracellular matrix as cancer targets. | Front Oncol | 2022 | 36203416 | PubTator, text mining | PubMed |
| Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. | Nature | 2022 | 36198802 | PubTator, text mining | PubMed |
| Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. | Nature | 2022 | 36198801 | PubTator, text mining | PubMed |
| Are off-target effects of imatinib the key to improving beta-cell function in diabetes? | Ups J Med Sci | 2022 | 36187072 | PubTator, text mining | PubMed |
| Pituitary corticotroph identity and receptor-mediated signaling: a transcriptomics perspective. | Curr Opin Endocr Metab Res | 2022 | 36177190 | PubTator, text mining | PubMed |
| Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event. | Front Oncol | 2022 | 36176390 | PubTator, text mining | PubMed |
| Circ_0001535 Facilitates Tumor Malignant Progression by miR-485-5p/LASP1 Axis in Colorectal Cancer | Balkan Med J | 2022 | 36172827 | PubTator, text mining | PubMed |
| New methodology of TMB assessment from tissue and liquid biopsy in NSCLC. | PLoS One | 2022 | 36155654 | PubTator, text mining | PubMed |
| Assessing the roles of collagen fiber morphology and matrix stiffness on ovarian cancer cell migration dynamics using multiphoton fabricated orthogonal image-based models. | Acta Biomater | 2022 | 36152908 | PubTator, text mining | PubMed |
| Potential gene identification and pathway crosstalk analysis of age-related macular degeneration. | Front Genet | 2022 | 36147504 | PubTator, text mining | PubMed |
| Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment. | Int J Mol Sci | 2022 | 36142424 | PubTator, text mining | PubMed |
| Ablation of Discoidin Domain Receptor 1 Provokes an Osteopenic Phenotype by Regulating Osteoblast/Osteocyte Autophagy and Apoptosis. | Biomedicines | 2022 | 36140274 | PubTator, text mining | PubMed |
| NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma. | Cancers (Basel) | 2022 | 36139554 | PubTator, text mining | PubMed |
| Temporal imaging of drug dynamics in live cells using stimulated Raman scattering microscopy and a perfusion cell culture system. | RSC Chem Biol | 2022 | 36128503 | PubTator, text mining | PubMed |
| Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance. | Front Oncol | 2022 | 36119516 | PubTator, text mining | PubMed |
| The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes? | J Exp Clin Cancer Res | 2022 | 36114508 | PubTator, text mining | PubMed |
| Autologous Protein Solution processing alters lymphoid and myeloid cell populations and modulates gene expression dependent on cell type. | Arthritis Res Ther | 2022 | 36096945 | PubTator, text mining | PubMed |
| Analyses of the expression and prognosis of ILDR1 in human gastric cancer. | Heliyon | 2022 | 36091962 | PubTator, text mining | PubMed |
| Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies. | Cancers (Basel) | 2022 | 36077813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=30